Cargando…
Performance comparison of aspirin assay between Anysis and VerifyNow: Assessment of therapeutic platelet inhibition in patients with cardiac diseases
BACKGROUND: Assessment of platelet inhibition for aspirin therapy is important to manage patients who are at potential risk of developing thrombotic and hemorrhagic complications. OBJECTIVE: This study aimed to evaluate a new platelet assay (Anysis-aspirin), compare it with VerifyNow-aspirin in pati...
Autores principales: | Piao, Jinxiang, Yoo, Chaeyoung, Kim, SeonYoung, Whang, Youn-Wha, Choi, Cheol Ung, Shin, Sehyun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
IOS Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8673509/ https://www.ncbi.nlm.nih.gov/pubmed/33967038 http://dx.doi.org/10.3233/CH-211171 |
Ejemplares similares
-
Performance comparison of the PFA-200 and Anysis-200: Assessment of bleeding risk screening in cardiology patients
por: Piao, Jinxiang, et al.
Publicado: (2021) -
Blood loss after coronary artery bypass by aspirin responsiveness assessed with preoperative VerifyNow aspirin testing
por: Willemsen, Laura M., et al.
Publicado: (2021) -
Periprocedural Variability of Platelet Functions in Carotid Artery Stenting: An Analysis Using VerifyNow
por: Yoshimura, Masataka, et al.
Publicado: (2021) -
Different Influences of Hematocrit on the Results of Two Point-Of-Care Platelet Function Tests, the VerifyNow Assay and Multiple Electrode Platelet Aggregometry
por: Kim, Yun Gi, et al.
Publicado: (2014) -
Impact of Routine Platelet Reactivity Testing with VerifyNow Assay on Antiplatelet Choice After Percutaneous Coronary Intervention
por: Mshelbwala, Fakilahyel S, et al.
Publicado: (2020)